Whole-genome sequencing that gets cheaper as the cohort grows.
We bundle whole-genome demand across research, pharma and clinical groups into a rate no single order can reach. Tell us your planned volume — you hear the price first and decide afterwards.
- Whole genome 30×, 120 Gb, PCR-free
- FASTQ, CRAM (GRCh38), VCF, QC report
- Annotation & filtering against your gene set
- Structured report in Atlas Portal
- Everything in Basic
- ACMG classification of variants in your gene set
- Expert review and prioritization
- Everything in Pro
- Physician-signed, case by case
Schematic. The tier logic is binding; the amounts for tiers 2–4 are published after 31 August — that's why they're not shown yet.
Sequencing is billed per run, not per sample. The larger the bundled volume, the lower the purchase price — and we pass that effect into the tiers.
The report is included in Basic because it is software. You only pay for what people do.
Specification
Sample logistics, status tracking and data delivery run through Atlas Portal.
What happens after 31 August
Once the cohort is set, we publish the tier prices and write to everyone who reserved. Anyone who wants to order receives a regular quote. Anyone who doesn't need do nothing.
For research institutions and companies. Not an offer to consumers.
What you can count on
We are the layer across labs — orchestration, interpretation and routing. This is what holds it together.
We operate to the ISO 17025 and 13485 standards across orchestration, interpretation and routing.
EU and Berlin data residency, with GDPR-compliant handling end to end.
Turnaround times are defined per service and quoted up front — no surprises.
Every sample is tracked from receipt to result under documented custody.
Transparent fixed prices. Direct services need no quote.
One point of contact across every method and lab we route to.